Study to assess the contribution of various blood samples and sampling techniques to the performance of a Self Monitoring Blood Glucose System.

Not Applicable

• Conditions: A glucose test used to monitor blood glucose results in patients diagnosed with diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12610000957099
• Lead Sponsor: niversal Biosensors Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-11-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients are required to be currently treated for type 1 or 2 diabetes and require a venous blood sample as part of their routine treatment.

Exclusion Criteria

Pregnant females, completed a D-Xylose Gut Absorption test within the last 2 days. Haematocrit and glucose to be within the acceptable range of the device

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glucose values from the device will correlate with results obtained from a laboratory test method[Glucose results from the laboratory method and device will be recorded immediately.]

Secondary Outcome Measures

Name	Time	Method
That various blood samples and sampling techniques will contribute to the performance of the device.[Glucose results from the laboratory method and device will be recorded immediately.]